Red List:Official warnings and scam reports, with sourcesCheck a link
NewsNews

CQC Rates Online Cannabis Clinic Alternaleaf 'Requires Improvement'

The regulator served Montu Group UK a warning notice in September 2025 and found prescribing not always in line with legislation or best practice.

This story is about the United Kingdom — not the country you picked in the header.

Close inspection of cannabis buds with gloves on
Photo: TeeFarm / Pixabay

Key takeaways

  • CQC inspected Montu Group UK Ltd, trading as Alternaleaf, on 22–29 July 2025.
  • A warning notice for safe care and treatment was served on 10 September 2025.
  • The report, published on 27 February 2026, rated the service 'requires improvement' overall.
  • Inspectors found breaches on safe care and treatment, premises and governance.
  • Alternaleaf said it had made clinical and operational changes and was challenging some findings.

England's health and social care regulator has rated one of the UK's online medical cannabis clinics "requires improvement" and served it with a warning notice. The Care Quality Commission (CQC) assessed Montu Group UK Ltd, trading as Alternaleaf, at its registered location in Winnersh, Wokingham, between 22 and 29 July 2025, and published its report on 27 February 2026.

What a warning notice means for Alternaleaf patients

CQC reports are one of the few independent checks patients have on how a private cannabis clinic prescribes. This is among the most detailed public findings so far on the sector, which now serves an estimated 95,000 to 140,000 patients.

What the CQC found

  1. CQC begins a responsive assessment, prompted by earlier concerns and the long period since registration without an inspection.

  2. Warning notice served for failing to comply with the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 on safe care and treatment.

  3. Report published: "requires improvement" overall, with "good" for how responsive the service is.

  • Breaches were identified in three areas: safe care and treatment, premises, and governance.
  • According to Cannabis Health News, inspectors found medicines were not always prescribed in line with current legislation or best practice, and some patients were encouraged to choose from a wide range of products without guidance on which suited their condition.
  • The same report described limited multidisciplinary review of prescribing, workforce pressures, and no evidence of training or references for one specialist doctor who had worked there for six weeks.
  • Patient feedback was mixed. The CQC recorded praise for a smooth, timely service alongside complaints of limited specialist input, and satisfaction audits reaching 87% between February and June 2025.
ItemCQC record
ProviderMontu Group UK Ltd, trading as Alternaleaf
Location140 Wharfedale Road, Winnersh, Wokingham RG41 5RB
ServicePrivate clinic treating patients prescribed unlicensed cannabis-based products for medicinal use
Assessment22–29 July 2025
EnforcementWarning notice, 10 September 2025
Overall ratingRequires improvement (report published 27 February 2026)

3

regulatory areas with breaches

CQC, February 2026

87%

patient satisfaction in the provider's own audits, Feb–Jun 2025

CQC, February 2026

The company's response

A spokesperson for Alternaleaf said it had implemented clinical and operational changes to strengthen its service since the inspection and had engaged in constructive dialogue with the CQC, including challenging some of the findings, according to Hemp Gazette. As of September 2026, the CQC continued to show the "requires improvement" rating, Cannabis Health News reported.

Re-inspection and the rating Montu must lift

A warning notice sets out what a provider must fix; the CQC can follow up with further inspection or enforcement if it doesn't. In May 2026 the Medical Cannabis Clinicians Society published updated best-practice prescribing guidelines, and the ACMD review of the 2018 medical cannabis rules remains outstanding. Patients can read any clinic's report free on cqc.org.uk; our guide to comparing UK cannabis clinics explains what to look for. The entry is also on the Red List.

Sources

  1. Care Quality Commission — Winnersh (Montu Group UK Ltd): inspection summary · checked Feb 2026
  2. Care Quality Commission — Winnersh: assessment report AP14599 · checked Feb 2026
  3. Cannabis Health News — CQC concerns add to scrutiny of UK's private medical cannabis sector · checked Sep 2026
  4. Hemp Gazette — CQC raises concerns over patient safety and prescribing practices at UK medical cannabis clinic · 2026
Filed underNewsUnited Kingdom

Verdex Editorial Team

Research & editing

The Verdex editorial team researches licensed cannabis sellers, strains and consumer-safety cases. Every factual claim is tied to a public source — license registers, regulator notices, lab data or published reviews — and listed on the page. We don’t accept payment for ratings, placements or removals.

More from the team How we fact-check

Was this story useful?

Comments

No comments yet

Questions, corrections or your own experience — start the conversation.

Leave a comment

A moderator reads every comment before it’s published.

Self-check · 2 minutes · private

Is cannabis becoming a problem for you?

Eight questions from CUDIT-R, a screening test used by clinicians. Your answers never leave this page.